☰

Peter M. Lauer, Ph.D. - Publications

Affiliations: 
2000 University of California, Berkeley, Berkeley, CA, United States 
Area:
Molecular and cellular basis of microbial pathogenesis
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hanson WG, Benanti EL, Lemmens EE, Liu W, Skoble J, Leong ML, Rae CS, Fassò M, Brockstedt DG, Chen C, Portnoy DA, Dubensky TW, Lauer P. A potent and effective suicidal vaccine platform. Infection and Immunity. PMID 31235641 DOI: 10.1128/Iai.00144-19  0.752
2019 Kim VM, Blair AB, Lauer P, Foley K, Che X, Soares K, Xia T, Muth ST, Kleponis J, Armstrong TD, Wolfgang CL, Jaffee EM, Brockstedt D, Zheng L. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies. Journal For Immunotherapy of Cancer. 7: 132. PMID 31113479 DOI: 10.1186/S40425-019-0601-5  0.344
2019 Zebertavage L, Bambina S, Shugart J, Alice A, Zens KD, Lauer P, Hanson B, Gough MJ, Crittenden MR, Bahjat KS. A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity. Plos One. 14: e0209153. PMID 30601871 DOI: 10.1371/Journal.Pone.0209153  0.399
2018 Johnson LE, Brockstedt D, Leong M, Lauer P, Theisen E, Sauer JD, McNeel DG. Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming. Oncoimmunology. 7: e1456603. PMID 30221049 DOI: 10.1080/2162402X.2018.1456603  0.626
2018 Deng W, Lira V, Hudson TE, Lemmens EE, Hanson WG, Flores R, Barajas G, Katibah GE, Desbien AL, Lauer P, Leong ML, Portnoy DA, Dubensky TW. Recombinant promotes tumor rejection by CD8 T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America. PMID 30038013 DOI: 10.1073/Pnas.1801910115  0.512
2017 Grubaugh D, Regeimbal JR, Ghosh P, Zhou Y, Lauer P, Dubensky TW, Higgins DE. The VirAB ABC transporter is required for VirR regulation of Listeria monocytogenes virulence and resistance to nisin. Infection and Immunity. PMID 29263107 DOI: 10.1128/Iai.00901-17  0.642
2017 Ortega FE, Rengarajan M, Chavez N, Radhakrishnan P, Gloerich M, Bianchini J, Siemers K, Luckett WS, Lauer P, Nelson WJ, Theriot JA. Adhesion to the host cell surface is sufficient to mediate Listeria monocytogenes entry into epithelial cells. Molecular Biology of the Cell. PMID 28877987 DOI: 10.1091/Mbc.E16-12-0851  0.336
2015 Jackson CM, Kochel CM, Nirschl CJ, Durham NM, Ruzevick J, Alme A, Francica BJ, Elias J, Daniels A, Dubensky TW, Lauer P, Brockstedt D, Baxi EG, Calabresi PA, Taube JM, et al. Systemic Tolerance Mediated by Melanoma Brain Tumors is Reversible by Radiotherapy and Vaccination. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26490306 DOI: 10.1158/1078-0432.Ccr-15-1516  0.328
2015 Fu J, Kanne DB, Leong M, Glickman LH, McWhirter SM, Lemmens E, Mechette K, Leong JJ, Lauer P, Liu W, Sivick KE, Zeng Q, Soares KC, Zheng L, Portnoy DA, et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Science Translational Medicine. 7: 283ra52. PMID 25877890 DOI: 10.1126/Scitranslmed.Aaa4306  0.562
2015 Reniere ML, Whiteley AT, Hamilton KL, John SM, Lauer P, Brennan RG, Portnoy DA. Glutathione activates virulence gene expression of an intracellular pathogen. Nature. 517: 170-3. PMID 25567281 DOI: 10.1038/Nature14029  0.57
2015 Crittenden M, Bahjat KS, Li R, Gore PA, Fountain C, Hanson B, Skoble J, Lauer P, Murphy A, Dubensky TW, Brockstedt DG, Urba WJ. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated Listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRvIII and NY-ESO-1, in patients with WHO grade III/IV astrocytomas. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps3106  0.744
2015 Crittenden M, Bahjat KS, Li R, Gore P, Fountain C, Hanson B, Skoble J, Lauer P, Murphy AL, Dubensky T, Brockstedt DG, Urba W. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas Journal For Immunotherapy of Cancer. 3: 162. DOI: 10.1186/2051-1426-3-S2-P162  0.717
2014 Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG, Dubensky TW, Hassan R, Armstrong TD, Jaffee EM. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology. 146: 1784-94.e6. PMID 24607504 DOI: 10.1053/J.Gastro.2014.02.055  0.337
2012 Dubensky TW, Skoble J, Lauer P, Brockstedt DG. Killed but metabolically active vaccines. Current Opinion in Biotechnology. 23: 917-23. PMID 22608846 DOI: 10.1016/J.Copbio.2012.04.005  0.732
2011 Sauer JD, Pereyre S, Archer KA, Burke TP, Hanson B, Lauer P, Portnoy DA. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proceedings of the National Academy of Sciences of the United States of America. 108: 12419-24. PMID 21746921 DOI: 10.1073/Pnas.1019041108  0.671
2011 Waite JC, Leiner I, Lauer P, Rae CS, Barbet G, Zheng H, Portnoy DA, Pamer EG, Dustin ML. Dynamic imaging of the effector immune response to listeria infection in vivo. Plos Pathogens. 7: e1001326. PMID 21455492 DOI: 10.1371/Journal.Ppat.1001326  0.55
2010 Sauer JD, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host & Microbe. 7: 412-9. PMID 20417169 DOI: 10.1016/J.Chom.2010.04.004  0.655
2010 Sinnathamby G, Lauer P, Zerfass J, Hanson B, Karabudak A, Krakover J, Secord AA, Clay TM, Morse MA, Dubensky TW, Brockstedt DG, Philip R, Giedlin M. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 856-69. PMID 19752748 DOI: 10.1097/CJI.0b013e3181b0b125  0.325
2008 Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. The Journal of Clinical Investigation. 118: 3990-4001. PMID 19033668 DOI: 10.1172/Jci31350  0.415
2008 Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill AV, Bartholomay LC, Harty JT. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proceedings of the National Academy of Sciences of the United States of America. 105: 14017-22. PMID 18780790 DOI: 10.1073/Pnas.0805452105  0.327
2008 Crimmins GT, Herskovits AA, Rehder K, Sivick KE, Lauer P, Dubensky TW, Portnoy DA. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proceedings of the National Academy of Sciences of the United States of America. 105: 10191-6. PMID 18632558 DOI: 10.1073/Pnas.0804170105  0.707
2008 Lauer P, Hanson B, Lemmens EE, Liu W, Luckett WS, Leong ML, Allen HE, Skoble J, Bahjat KS, Freitag NE, Brockstedt DG, Dubensky TW. Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains. Infection and Immunity. 76: 3742-53. PMID 18541651 DOI: 10.1128/Iai.00390-08  0.75
2002 Lauer P, Chow MY, Loessner MJ, Portnoy DA, Calendar R. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. Journal of Bacteriology. 184: 4177-86. PMID 12107135 DOI: 10.1128/Jb.184.15.4177-4186.2002  0.521
2001 Lauer P, Theriot JA, Skoble J, Welch MD, Portnoy DA. Systematic mutational analysis of the amino-terminal domain of the Listeria monocytogenes ActA protein reveals novel functions in actin-based motility. Molecular Microbiology. 42: 1163-77. PMID 11886549 DOI: 10.1046/J.1365-2958.2001.02677.X  0.702
Show low-probability matches.